{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T13:23:14Z","timestamp":1782998594637,"version":"3.54.5"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["11371174"],"award-info":[{"award-number":["11371174"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["11804123"],"award-info":[{"award-number":["11804123"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Postgraduate Research & Practice Innovation Program of Jiangsu Province","award":["KYCX18_1866"],"award-info":[{"award-number":["KYCX18_1866"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Interdiscip Sci Comput Life Sci"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s12539-020-00366-8","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T17:02:32Z","timestamp":1586970152000},"page":"226-236","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Gene Biomarkers Derived from Clinical Data of Hepatocellular Carcinoma"],"prefix":"10.1007","volume":"12","author":[{"given":"Jiaming","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4018-9114","authenticated-orcid":false,"given":"Xu-Qing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaolai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,15]]},"reference":[{"issue":"30","key":"366_CR1","doi-asserted-by":"publisher","first-page":"10249","DOI":"10.3748\/wjg.v20.i30.10249","volume":"20","author":"LL Han","year":"2014","unstructured":"Han LL, Lv Y, Guo H et al (2014) Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy. World J Gastroenterol 20(30):10249\u201310261. https:\/\/doi.org\/10.3748\/wjg.v20.i30.10249","journal-title":"World J Gastroenterol"},{"issue":"2","key":"366_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jcmgh.2017.06.003","volume":"4","author":"JU Kim","year":"2017","unstructured":"Kim JU, Cox IJ, Taylor-Robinson SD (2017) The quest for relevant hepatocellular carcinoma biomarkers. Cell Mol Gastroenterol Hepatol 4(2):283\u2013284. https:\/\/doi.org\/10.1016\/j.jcmgh.2017.06.003","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"3","key":"366_CR3","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.amjsurg.2015.03.027","volume":"210","author":"T Miura","year":"2015","unstructured":"Miura T, Ban D, Tanaka S et al (2015) Distinct clinicopathological phenotype of hepatocellular carcinoma with ethoxybenzyl-magnetic resonance imaging hyperintensity: association with gene expression signature. Am J Surg 210(3):561\u2013569. https:\/\/doi.org\/10.1016\/j.amjsurg.2015.03.027","journal-title":"Am J Surg"},{"issue":"1","key":"366_CR4","doi-asserted-by":"publisher","first-page":"10570","DOI":"10.1038\/s41598-017-11029-y","volume":"7","author":"C Zhou","year":"2017","unstructured":"Zhou C, Zhang W, Chen W et al (2017) Integrated analysis of copy number variations and gene expression profiling in hepatocellular carcinoma. Sci Rep 7(1):10570. https:\/\/doi.org\/10.1038\/s41598-017-11029-y","journal-title":"Sci Rep"},{"issue":"1","key":"366_CR5","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1186\/1471-2164-15-S1-S13","volume":"15","author":"L Wei","year":"2014","unstructured":"Wei L, Lian B, Zhang Y et al (2014) Application of microRNA and mRNA expression profiling on prognostic biomarker discovery for hepatocellular carcinoma. BMC Genomics 15(1):S13. https:\/\/doi.org\/10.1186\/1471-2164-15-S1-S13","journal-title":"BMC Genomics"},{"key":"366_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature07638","volume":"458","author":"CA Maher","year":"2009","unstructured":"Maher CA, Kumar-Sinha C, Cao XH et al (2009) Transcriptome sequencing to detect gene fusions in cancer. Nature 458:97\u2013101. https:\/\/doi.org\/10.1038\/nature07638","journal-title":"Nature"},{"key":"366_CR7","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nmeth.1503","volume":"7","author":"M Griffith","year":"2010","unstructured":"Griffith M, Griffith OL, Mwenifumbo J et al (2010) Alternative expression analysis by RNA sequencing. Nat Methods 7:843\u2013847. https:\/\/doi.org\/10.1038\/nmeth.1503","journal-title":"Nat Methods"},{"issue":"30","key":"366_CR8","doi-asserted-by":"publisher","first-page":"12353","DOI":"10.1073\/pnas.0904720106","volume":"106","author":"CA Maher","year":"2009","unstructured":"Maher CA, Palanisamy N, Brenner JC et al (2009) Chimeric transcript discovery by paired-end transcriptome sequencing. Proc Natl Acad Sci 106(30):12353\u201312358. https:\/\/doi.org\/10.1073\/pnas.0904720106","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"366_CR9","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1093\/nar\/gks042","volume":"40","author":"DJ McCarthy","year":"2012","unstructured":"McCarthy DJ, Chen Y, Smyth GK et al (2012) Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res 40(10):4288\u20134297. https:\/\/doi.org\/10.1093\/nar\/gks042","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"366_CR10","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1073\/pnas.0812945106","volume":"106","author":"Q Zhao","year":"2009","unstructured":"Zhao Q, Caballero OL, Levy S et al (2009) Transcriptome-guided characterization of genomic rearrangements in a breast cancer cell line. Proc Natl Acad Sci 106(6):1886\u20131891. https:\/\/doi.org\/10.1073\/pnas.0812945106","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"366_CR11","doi-asserted-by":"publisher","first-page":"e40092","DOI":"10.1371\/journal.pone.0040092","volume":"7","author":"D Sinicropi","year":"2012","unstructured":"Sinicropi D, Qu K, Collin F et al (2012) Whole transcriptome RNA-Seq analysis of breast cancer recurrence risk using formalin-fixed paraffin-embedded tumor tissue. PLoS ONE 7(7):e40092. https:\/\/doi.org\/10.1371\/journal.pone.0040092","journal-title":"PLoS ONE"},{"key":"366_CR12","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/cr.2012.30","volume":"22","author":"S Ren","year":"2012","unstructured":"Ren S, Peng Z, Mao JH et al (2012) RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings. Cell Res 22:806\u2013821. https:\/\/doi.org\/10.1038\/cr.2012.30","journal-title":"Cell Res"},{"issue":"26","key":"366_CR13","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1056\/NEJMoa0902542","volume":"360","author":"SP Shah","year":"2009","unstructured":"Shah SP, K\u00f6bel M, Senz J et al (2009) Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med 360(26):2719\u20132729. https:\/\/doi.org\/10.1056\/NEJMoa0902542","journal-title":"N Engl J Med"},{"issue":"6","key":"366_CR14","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1158\/1940-6207.CAPR-11-0212","volume":"4","author":"J Beane","year":"2011","unstructured":"Beane J, Vick J, Schembri F et al (2011) Characterizing the impact of smoking and lung cancer on the airway transcriptome using RNA-Seq. Cancer Prev Res 4(6):803\u2013817. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-11-0212","journal-title":"Cancer Prev Res"},{"issue":"5","key":"366_CR15","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.3892\/ol.2019.10811","volume":"18","author":"J Liu","year":"2019","unstructured":"Liu J, Yu Z, Sun M et al (2019) Identification of cancer\/testis antigen 2 gene as a potential hepatocellular carcinoma therapeutic target by hub gene screening with topological analysis. Oncol Lett 18(5):4778\u20134788. https:\/\/doi.org\/10.3892\/ol.2019.10811","journal-title":"Oncol Lett"},{"issue":"4","key":"366_CR16","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3390\/ijms18040722","volume":"18","author":"Y Guo","year":"2017","unstructured":"Guo Y, Bao Y, Ma M et al (2017) Identification of key candidate genes and pathways in colorectal cancer by integrated bioinformatical analysis. Int J Mol Sci 18(4):722. https:\/\/doi.org\/10.3390\/ijms18040722","journal-title":"Int J Mol Sci"},{"key":"366_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cancergen.2017.06.002","volume":"216","author":"R Agarwal","year":"2017","unstructured":"Agarwal R, Narayan J, Bhattacharyya A et al (2017) Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targets. Cancer Genetics 216:37\u201351. https:\/\/doi.org\/10.1016\/j.cancergen.2017.06.002","journal-title":"Cancer Genetics"},{"key":"366_CR18","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/srep00342","volume":"2","author":"L Chen","year":"2012","unstructured":"Chen L, Liu R, Liu ZP et al (2012) Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers. Sci Rep 2:342. https:\/\/doi.org\/10.1038\/srep00342","journal-title":"Sci Rep"},{"issue":"1","key":"366_CR19","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/1755-8794-7-S1-S3","volume":"7","author":"Y Li","year":"2014","unstructured":"Li Y, Vongsangnak W, Chen L et al (2014) Integrative analysis reveals disease-associated genes and biomarkers for prostate cancer progression. BMC Med Genomics 7(1):S3. https:\/\/doi.org\/10.1186\/1755-8794-7-S1-S3","journal-title":"BMC Med Genomics"},{"issue":"2","key":"366_CR20","doi-asserted-by":"publisher","first-page":"278","DOI":"10.7150\/jca.17302","volume":"8","author":"X Yuan","year":"2017","unstructured":"Yuan X, Chen J, Lin Y et al (2017) Network biomarkers constructed from gene expression and protein-protein interaction data for accurate prediction of leukemia. J Cancer 8(2):278\u2013286. https:\/\/doi.org\/10.7150\/jca.17302","journal-title":"J Cancer"},{"issue":"9","key":"366_CR21","doi-asserted-by":"publisher","first-page":"e106748","DOI":"10.1371\/journal.pone.0106748","volume":"9","author":"X Sol\u00e9","year":"2014","unstructured":"Sol\u00e9 X, Crous-Bou M, Cordero D et al (2014) Discovery and validation of new potential biomarkers for early detection of colon cancer. PLoS ONE 9(9):e106748. https:\/\/doi.org\/10.1371\/journal.pone.0106748","journal-title":"PLoS ONE"},{"key":"366_CR22","doi-asserted-by":"publisher","DOI":"10.2202\/1544-6115.1128","author":"B Zhang","year":"2005","unstructured":"Zhang B, Horvath S (2005) A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. https:\/\/doi.org\/10.2202\/1544-6115.1128","journal-title":"Stat Appl Genet Mol Biol"},{"issue":"5586","key":"366_CR23","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1126\/science.1073374","volume":"297","author":"E Ravasz","year":"2002","unstructured":"Ravasz E, Somera AL, Mongru DA et al (2002) Hierarchical organization of modularity in metabolic networks. Science 297(5586):1551\u20131555. https:\/\/doi.org\/10.1126\/science.1073374","journal-title":"Science"},{"issue":"1","key":"366_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1752-0509-1-54","volume":"1","author":"P Langfelder","year":"2007","unstructured":"Langfelder P, Horvath S (2007) Eigengene networks for studying the relationships between co-expression modules. BMC Syst Biol 1(1):54. https:\/\/doi.org\/10.1186\/1752-0509-1-54","journal-title":"BMC Syst Biol"},{"key":"366_CR25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12916-017-0973-7","volume":"15","author":"S Yoo","year":"2017","unstructured":"Yoo S, Wang W, Wang Q et al (2017) A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis. BMC Med 15:214. https:\/\/doi.org\/10.1186\/s12916-017-0973-7","journal-title":"BMC Med"},{"issue":"21","key":"366_CR26","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.1158\/1078-0432.CCR-06-2236","volume":"13","author":"SM Wang","year":"2007","unstructured":"Wang SM, Ooi LL, Hui KM (2007) Identification and validation of a novel gene signature associated with the recurrence of human hepatocellular carcinoma. Clin Cancer Res 13(21):6275\u20136283. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-2236","journal-title":"Clin Cancer Res"},{"key":"366_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41586-019-0987-8","volume":"567","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Sun A, Zhao Y et al (2019) Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma. Nature 567:257\u2013261. https:\/\/doi.org\/10.1038\/s41586-019-0987-8","journal-title":"Nature"},{"key":"366_CR28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/432293a","volume":"432","author":"B Marte","year":"2004","unstructured":"Marte B (2004) Cell division and cancer. Nature 432:293. https:\/\/doi.org\/10.1038\/432293a","journal-title":"Nature"},{"key":"366_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/hep.28509","volume":"64","author":"C Liu","year":"2016","unstructured":"Liu C, Liu L, Chen X et al (2016) Sox9 regulates self-renewal and tumorigenicity by promoting symmetrical cell division of cancer stem cells in hepatocellular carcinoma. Hepatology 64:117\u2013129. https:\/\/doi.org\/10.1002\/hep.28509","journal-title":"Hepatology"},{"issue":"4","key":"366_CR30","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3978\/j.issn.1000-9604.2014.08.01","volume":"26","author":"Q Liu","year":"2014","unstructured":"Liu Q, Yang P, Tu K et al (2014) TPX2 knockdown suppressed hepatocellular carcinoma cell invasion via inactivating AKT signaling and inhibiting MMP2 and MMP9 expression. Chin J Cancer Res 26(4):410\u2013417. https:\/\/doi.org\/10.3978\/j.issn.1000-9604.2014.08.01","journal-title":"Chin J Cancer Res"},{"issue":"4","key":"366_CR31","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.18632\/oncotarget.2764","volume":"6","author":"LH Wang","year":"2015","unstructured":"Wang LH, Yen CJ, Li TN et al (2015) Sgo1 is a potential therapeutic target for hepatocellular carcinoma. Oncotarget 6(4):2023\u20132033. https:\/\/doi.org\/10.18632\/oncotarget.2764","journal-title":"Oncotarget"},{"issue":"6","key":"366_CR32","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S0168-8278(03)00458-6","volume":"39","author":"L Gramantieri","year":"2003","unstructured":"Gramantieri L, Trer\u00e8 D, Chieco P et al (2003) In human hepatocellular carcinoma in cirrhosis proliferating cell nuclear antigen (PCNA) is involved in cell proliferation and cooperates with P21 in DNA repair. J Hepatol 39(6):997\u20131003. https:\/\/doi.org\/10.1016\/S0168-8278(03)00458-6","journal-title":"J Hepatol"},{"issue":"1","key":"366_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/00000658-199801000-00008","volume":"227","author":"JR Lukish","year":"1998","unstructured":"Lukish JR, Muro K, DeNobile J et al (1998) Prognostic significance of DNA replication errors in young patients with colorectal cancer. Ann Surg 227(1):51\u201356. https:\/\/doi.org\/10.1097\/00000658-199801000-00008","journal-title":"Ann Surg"},{"key":"366_CR34","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1002\/hep.22542","volume":"48","author":"S Martin-Lluesma","year":"2008","unstructured":"Martin-Lluesma S, Schaeffer C, Robert EI et al (2008) Hepatitis B virus X protein affects S phase progression leading to chromosome segregation defects by binding to damaged DNA binding protein 1. Hepatology 48:1467\u20131476. https:\/\/doi.org\/10.1002\/hep.22542","journal-title":"Hepatology"},{"issue":"3","key":"366_CR35","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.bbrc.2005.12.089","volume":"340","author":"BK Wu","year":"2006","unstructured":"Wu BK, Li CC, Chen HJ et al (2006) Blocking of G1\/S transition and cell death in the regenerating liver of Hepatitis B virus X protein transgenic mice. Biochem Biophys Res Commun 340(3):916\u2013928. https:\/\/doi.org\/10.1016\/j.bbrc.2005.12.089","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"366_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/2047-783X-18-35","volume":"18","author":"L Zhang","year":"2013","unstructured":"Zhang L, Guo Y, Li B et al (2013) Identification of biomarkers for hepatocellular carcinoma using network-based bioinformatics methods. Eur J Med Res 18(1):35. https:\/\/doi.org\/10.1186\/2047-783X-18-35","journal-title":"Eur J Med Res"},{"key":"366_CR37","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc2602","volume":"9","author":"M Malumbres","year":"2009","unstructured":"Malumbres M, Barbacid M (2009) Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9:153\u2013166. https:\/\/doi.org\/10.1038\/nrc2602","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"366_CR38","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.gpb.2013.05.007","volume":"11","author":"M ElHefnawi","year":"2013","unstructured":"ElHefnawi M, Soliman B, Abu-Shahba N et al (2013) An integrative meta-analysis of microRNAs in hepatocellular carcinoma. Genom Proteom Bioinf 11(6):354\u2013367. https:\/\/doi.org\/10.1016\/j.gpb.2013.05.007","journal-title":"Genom Proteom Bioinf"},{"key":"366_CR39","doi-asserted-by":"publisher","first-page":"391475","DOI":"10.1155\/2015\/391475","volume":"2015","author":"YH Wong","year":"2015","unstructured":"Wong YH, Wu CC, Lin CL et al (2015) Applying NGS data to find evolutionary network biomarkers from the early and late stages of hepatocellular carcinoma. Biomed Res Int 2015:391475. https:\/\/doi.org\/10.1155\/2015\/391475","journal-title":"Biomed Res Int"},{"issue":"3","key":"366_CR40","doi-asserted-by":"publisher","first-page":"453","DOI":"10.33549\/physiolres.932115","volume":"60","author":"T Hucl","year":"2011","unstructured":"Hucl T (2011) Gallmeier E (2011) DNA repair: exploiting the Fanconi anemia pathway as a potential therapeutic target. Physiol Res 60(3):453\u2013465. https:\/\/doi.org\/10.33549\/physiolres.932115","journal-title":"Physiol Res"},{"key":"366_CR41","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/1476-4598-9-127","volume":"9","author":"A Palagyi","year":"2010","unstructured":"Palagyi A, Neveling K, Plinninger U et al (2010) Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents. Mol Cancer 9:127. https:\/\/doi.org\/10.1186\/1476-4598-9-127","journal-title":"Mol Cancer"},{"key":"366_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1349-7006.1995.tb02979.x","volume":"86","author":"A Okayama","year":"1995","unstructured":"Okayama A, Maruyama T, Tachibana N et al (1995) Increased prevalence of HTLV-I infection in patients with hepatocellular carcinoma associated with Hepatitis C virus. Cancer Sci 86:1\u20134. https:\/\/doi.org\/10.1111\/j.1349-7006.1995.tb02979.x","journal-title":"Cancer Sci"},{"issue":"4","key":"366_CR43","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/annonc\/mdq468","volume":"22","author":"EH Lips","year":"2010","unstructured":"Lips EH, Mulder L, Hannemann J et al (2010) Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapy. Ann Oncol 22(4):870\u2013876. https:\/\/doi.org\/10.1093\/annonc\/mdq468","journal-title":"Ann Oncol"},{"key":"366_CR44","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1038\/bjc.2012.451","volume":"107","author":"V Abkevich","year":"2012","unstructured":"Abkevich V, Timms KM, Hennessy BT et al (2012) Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer. Br J Cancer 107:1776\u20131782. https:\/\/doi.org\/10.1038\/bjc.2012.451","journal-title":"Br J Cancer"},{"issue":"6","key":"366_CR45","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/carcin\/bgq064","volume":"31","author":"T Helleday","year":"2010","unstructured":"Helleday T (2010) Homologous recombination in cancer development, treatment and development of drug resistance. Carcinogenesis 31(6):955\u2013960. https:\/\/doi.org\/10.1093\/carcin\/bgq064","journal-title":"Carcinogenesis"},{"issue":"7","key":"366_CR46","first-page":"1059","volume":"3","author":"A Kiss","year":"1997","unstructured":"Kiss A, Wang NJ, Xie JP et al (1997) Analysis of transforming growth factor (TGF)-alpha\/epidermal growth factor receptor, hepatocyte growth Factor\/c-met, TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas. Clin Cancer Res 3(7):1059\u20131066","journal-title":"Clin Cancer Res"},{"issue":"50","key":"366_CR47","doi-asserted-by":"publisher","first-page":"7410","DOI":"10.1038\/sj.onc.1209086","volume":"24","author":"EL Greer","year":"2005","unstructured":"Greer EL, Brunet A (2005) FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24(50):7410\u20137425. https:\/\/doi.org\/10.1038\/sj.onc.1209086","journal-title":"Oncogene"},{"issue":"1","key":"366_CR48","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1038\/s41598-017-01832-y","volume":"7","author":"Q Guo","year":"2017","unstructured":"Guo Q, Song Y, Hua K et al (2017) Involvement of FAK-ERK2 signaling pathway in CKAP2-induced proliferation and motility in cervical carcinoma cell lines. Sci Rep 7(1):2117. https:\/\/doi.org\/10.1038\/s41598-017-01832-y","journal-title":"Sci Rep"},{"issue":"1","key":"366_CR49","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.surg.2013.06.009","volume":"155","author":"T Hayashi","year":"2014","unstructured":"Hayashi T, Ohtsuka M, Okamura D et al (2014) Cytoskeleton-associated protein 2 is a potential predictive marker for risk of early and extensive recurrence of hepatocellular carcinoma after operative resection. Surgery 155(1):114\u2013123. https:\/\/doi.org\/10.1016\/j.surg.2013.06.009","journal-title":"Surgery"},{"issue":"13","key":"366_CR50","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1158\/1538-7445.AM2017-3113","volume":"77","author":"TW Jeon","year":"2017","unstructured":"Jeon TW, Min JK, Seo YR et al (2017) Abstract 3113: Knockdown of cell division cycle-associated 8 (CDCA8) suppresses hepatocellular carcinoma growth via the upregulation of tumor suppressor ATF3. Can Res 77(13):3113\u20133113. https:\/\/doi.org\/10.1158\/1538-7445.AM2017-3113","journal-title":"Can Res"},{"issue":"6","key":"366_CR51","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.3892\/ijo.2018.4348","volume":"52","author":"X Fu","year":"2018","unstructured":"Fu X, Zhu Y, Zheng B et al (2018) KIFC1, a novel potential prognostic factor and therapeutic target in hepatocellular carcinoma. Int J Oncol 52(6):1912\u20131922. https:\/\/doi.org\/10.3892\/ijo.2018.4348","journal-title":"Int J Oncol"},{"issue":"1","key":"366_CR52","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.canlet.2016.09.017","volume":"383","author":"H Xia","year":"2016","unstructured":"Xia H, Kong SN, Chen J et al (2016) MELK is an oncogenic kinase essential for early hepatocellular carcinoma recurrence. Cancer Lett 383(1):85\u201393. https:\/\/doi.org\/10.1016\/j.canlet.2016.09.017","journal-title":"Cancer Lett"},{"issue":"1","key":"366_CR53","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12935-017-0471-1","volume":"17","author":"Y Li","year":"2017","unstructured":"Li Y, Li Y, Chen Y et al (2017) MicroRNA-214-3p inhibits proliferation and cell cycle progression by targeting MELK in hepatocellular carcinoma and correlates cancer prognosis. Cancer Cell Int 17(1):102. https:\/\/doi.org\/10.1186\/s12935-017-0471-1","journal-title":"Cancer Cell Int"},{"key":"366_CR54","first-page":"1747","volume":"10","author":"Y Li","year":"2017","unstructured":"Li Y, Zheng J, Yao J et al (2017) Aberrant expression and prognostic value of RacGAP1 in hepatocellular carcinoma. Int J Clin Exp Pathol 10:1747\u20131755","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"366_CR55","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cell.2007.04.044","volume":"130","author":"MR Junttila","year":"2007","unstructured":"Junttila MR, Puustinen P, Niemel\u00e4 M et al (2007) CIP2A inhibits PP2A in human malignancies. Cell 130(1):51\u201362. https:\/\/doi.org\/10.1016\/j.cell.2007.04.044","journal-title":"Cell"},{"key":"366_CR56","doi-asserted-by":"publisher","first-page":"6257","DOI":"10.1038\/onc.2010.357","volume":"29","author":"KF Chen","year":"2010","unstructured":"Chen KF, Liu CY, Lin YC et al (2010) CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells. Oncogene 29:6257\u20136266. https:\/\/doi.org\/10.1038\/onc.2010.357","journal-title":"Oncogene"},{"issue":"16","key":"366_CR57","doi-asserted-by":"publisher","first-page":"5092","DOI":"10.1158\/1078-0432.CCR-08-3283","volume":"15","author":"C C\u00f4me","year":"2009","unstructured":"C\u00f4me C, Laine A, Chanrion M et al (2009) CIP2A is associated with human breast cancer aggressivity. Clin Cancer Res 15(16):5092\u20135100. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-3283","journal-title":"Clin Cancer Res"},{"issue":"12","key":"366_CR58","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1158\/1078-0432.CCR-07-4137","volume":"14","author":"W Li","year":"2008","unstructured":"Li W, Ge Z, Liu C et al (2008) CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells. Clin Cancer Res 14(12):3722\u20133728. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-4137","journal-title":"Clin Cancer Res"},{"issue":"11","key":"366_CR59","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/jnci\/djp103","volume":"101","author":"A Khanna","year":"2009","unstructured":"Khanna A, B\u00f6ckelman C, Hemmes A et al (2009) MYC-dependent regulation and prognostic role of CIP2A in gastric cancer. J Natl Cancer Inst 101(11):793\u2013805. https:\/\/doi.org\/10.1093\/jnci\/djp103","journal-title":"J Natl Cancer Inst"}],"container-title":["Interdisciplinary Sciences: Computational Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12539-020-00366-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12539-020-00366-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12539-020-00366-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T07:48:24Z","timestamp":1618472904000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12539-020-00366-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,15]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["366"],"URL":"https:\/\/doi.org\/10.1007\/s12539-020-00366-8","relation":{},"ISSN":["1913-2751","1867-1462"],"issn-type":[{"value":"1913-2751","type":"print"},{"value":"1867-1462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,15]]},"assertion":[{"value":"9 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare no conflicts of interest in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}